RxDoctor Payments Data

Clinical Molecular Genetics: industry payments

Drug and device makers reported $1,495,490 in payments to providers registered in this specialty across Open Payments program years 20192025.

Providers
34
Received a payment
34 (100.0%)
Total reported
$1.5M
Average, those paid
$43,985

The average is computed only over providers who received something, because including the 0 who received nothing would produce a number that describes neither group. Totals are dominated by a small number of large royalty and consulting arrangements; the typical payment in this specialty is far smaller than the average implies.

What Medicare pays clinical molecular genetics clinicians

Part B allowed per clinician, 2024
$21,600
Of which, services
$21,600
Clinicians billing Part B
7

Across 7 clinical molecular genetics clinicians who billed Original Medicare Part B in 2024, Medicare allowed $151,200 in total — an average of $21,600 each, of which $21,600 was for services and the rest for drugs administered in the office.

This is not a salary. The rest is what Medicare allowed for services these clinicians billed — Original Medicare fee-for-service only. It excludes Medicare Advantage, which now covers more than half of Medicare enrollees, along with Medicaid and every commercial insurer, so for most clinicians it is a fraction of their practice. It is also gross revenue: staff, rent, supplies and malpractice premiums all come out of it before anyone is paid. Anyone quoting a figure like this as physician pay is misreading it.

By state

StateProvidersTotal reportedPer provider
Texas5$1,310,739$262,148
Indiana4$168,425$42,106
Washington3$7,284$2,428
Puerto Rico1$4,389$4,389
Georgia1$2,257$2,257
Florida3$760$253
California3$434$145
Tennessee2$338$169
New York3$288$96
Iowa1$190$190
North Carolina1$105$105
Minnesota1$100$100
New Jersey1$47$47
Alabama1$43$43
Utah1$31$31
Connecticut1$25$25
Massachusetts1$20$20
Pennsylvania1$13$13